September 17-18, 2011
Registration will be limited to 50 participants.
Erika Schwartz, M.D. | David Brownstein, M.D. | Joseph Raffaele, M.D | Randi Mann, WHNP-BC, CNMP
Special Offer: 12 AMA/PRA Catergory 1 CME credits available to participants registering for the optional online course curriculum. Learn more...
This one and one-half day symposium includes basic science, current research, and extensive clinical application of female and male hormone replacement therapies and other evidence-based integrative therapies for the treatment of the symptoms of hormone imbalance, the prevention of disease, and the management of aging.
Symposium format will include physician participation and review of clinical protocols and case studies. Interactive study materials, including articles, and extensive survey of past and current PubMed literature will be available online to all participants prior to the symposium.
Presenters will also focus on personal experience and practical advice for building and growing a successful practice.
THIS SYMPOSIUM WILL COVER THE FOLLOWING TOPICS:
Registration includes breakfast, lunch, and private, chef-catered networking dinner and wine tasting at the historic Madison Club.
About Our Presenters
| Erika Schwartz, M.D. |
|Dr. Schwartz is the Founder and Chief Medical Officer of AgeMD, the Age Management Institute and a Founding Director of the Bioidentical Hormone Initiative. She is a member of NAMS, MSSNY, AACOG, AFTRA/SAG, NYSSIM and sits on the Board of Managers and Trustees at SUNY Downstate College of Medicine. Since starting her distinguished career, Dr. Schwartz has been committed to empowering patients and teaching physicians compassion alongsideinnovative scientific and clinical approaches. She is a leading expert in the field of BHRT, wellness, and disease prevention and is the author of four best-selling books. Dr. Schwartz has been by-lined in The Wall Street Journal,The New York Times, and is an international speaker and television personality.|
David Brownstein, M.D.
|A board-certified family physician, Dr. Brownstein is the Medical Director of the Center for Holistic Medicine in West Bloomfield, Michigan and a Founding Director of the Bioidentical Hormone Initiative. He is one of the foremost practitioners of holistic medicine in the United States. He received his undergraduate degree from the University of Michigan and medical degree from Wayne State University School of Medicine.Dr. Brownstein has lectured internationally to physicians and others about his success in using natural hormone and nutritional therapies in his practice and has authored ten books, including eight national best sellers.|
Joseph Raffaele, M.D.
|Dr. Raffaele received his B.A. from Princeton University and his M.D. from Hahnemann University Medical School in 1989. He is board-certified in internal medicine and is a diplomat of the American Board of Anti-Aging Medicine. In 1995, Dr. Raffaele began researching and developing a scientifically based treatment program and co-founded PhysioAge Medical Group, a clinical practice focused on age management medicine. In 2003 he started researching and measuring biomarkers of aging, and then conducted a clinical study using those biomarkers most highly correlated with age. The results of that study determined the algorithms used by the PhysioAge Systems software to calculate physiological age.|
Randi Mann, WHNP-BC, NCMP
|Ms. Mann is a board certified Women’s Health Nurse Practitioner and the founder of Wise Woman Wellness, in De Pere, Wisconsin. Ms. Mann has been helping women live healthier and more abundant, joy filled lives for over 26 years, combining the best of conventional and integrative/complimentary medicine with a blend of compassion, cutting edge science, practical guidance and humor to create an individualized road map to the Midlife transition for each of her patients. She has recognized expertise in menopausal medicine and is certified by the North American Menopause Society (NAMS) as a Menopause Practitioner.|
Whitney Wharton, PhD.
Special Guest Lecture: Estradiol and Alzheimer’s Disease
Recent NIH Sponsored Research at the University of Wisconsin School of Medicine and Public Health showed that using estradiol may be cognitively beneficial for post-menopausal women with mild to moderate Alzheimer’s disease.
Dr. Wharton, the study’s lead researcher and author of an upcoming paper in the Journal of Alzheimer’s Disease will present these important findings and discuss their relevance to age management therapies and overall cognitive health for aging patients.
This Symposium will be held at:
Hilton Madison Monona Terrace, 9 East Wilson Street, Madison, WI 53703
$149/night – Reserve rooms by August 17, 2011
Call: 1-866-403-8838 or 414-935-5941
For discount pricing use Group Code: RSTH
Or for more information, email us at: email@example.com
The Bioidentical Hormone Initiative is a community of physicians who are dedicated to the treatment of age-related endocrine dysfunction with bioidentical hormones and other evidence-based integrative therapies.
Our experience, based on the successful treatment of tens-of-thousands of patients and backed by extensive clinical and scientific research, proves the effectiveness of these therapies.
BHI's goal is to serve as a source of information, educational resources and professional dialog, to encourage the exchange of ideas, and to promote the knowledge required for the successful implementation of bioidentical hormone therapies and other integrative therapies in the medical practice.
We believe that bioidentical hormones, together with closely calibrated nutritional and lifestyle therapies, can help our patients improve their quality of life, prevent chronic illness, and obtain optimal health.
AgeMD, the Age Management Institute; Restore Health; Physioage Medical Group; Wise Woman Wellness; Center for Holistic Medicine.